But, but, but, Gilead does no wrong. Laughing at the fact that someone would post such nonsense. I guess they should do a little more DD before posting such garbage.
CYDY will rule!!
Maybe they should go back to SA where they spent most of their time telling tall tales.
The Merck drug failed. Perhaps you should look at Gilead's capsid inhibitor trials -- expected trial 2/28/22, before LL will even be filed. Safety=placebo. Efficacy 81-95%, LL 81%. Twice a year dosing to 52 times. Advanced trial for PrEP (no LL PrEP trial even envisioned), HIV mono in advanced development. LL HIV mono???